Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment [clinicaltrials_resource:5bed5a45f6b716094c56d2ae1622c5ee]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment [clinicaltrials_resource:5bed5a45f6b716094c56d2ae1622c5ee]
Bio2RDF identifier
5bed5a45f6b716094c56d2ae1622c5ee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5bed5a45f6b716094c56d2ae1622c5ee
measure [clinicaltrials_vocabulary:measure]
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment
identifier
clinicaltrials_resource:5bed5a45f6b716094c56d2ae1622c5ee
title
Safety of vildagliptin in combination with glimepiride during 52 weeks of treatment
@en
type
label
Safety of vildagliptin in comb ...... d5a45f6b716094c56d2ae1622c5ee]
@en